Skip to main content
. 2023 Jul 5;112(11):1620–1638. doi: 10.1007/s00392-023-02240-1

Table 3.

Baseline characteristics (d-dimer  > 2ULN)

Rivaroxaban (N = 43) SOC (N = 45) Total (N = 88)
Age at inclusion (years)
 Mean (SD) 63.000 (14.248) 63.911 (16.662) 63.466 (15.447)
Sex
 Female 18 (41.9%) 16 (35.6%) 34 (38.6%)
 Male 25 (58.1%) 29 (64.4%) 54 (61.4%)
Weight (kg)
 Mean (SD) 85.233 (17.514) 85.342 (16.831) 85.287 (17.075)
BMI (kg/m2)
 Mean (SD) 28.763 (4.913) 27.972 (4.120) 28.367 (4.524)
Hospitalization on inclusion
 No 0 (0.0%) 1 (2.2%) 1 (1.1%)
 Yes 43 (100.0%) 44 (97.8%) 87 (98.9%)
Asthma
 Yes 3 (7.0%) 1 (2.2%) 4 (4.5%)
COPD
 Yes 2 (4.7%) 3 (6.7%) 5 (5.7%)
Diabetes mellitus
 Yes 9 (20.9%) 6 (13.3%) 15 (17.0%)
Chronic heart failure
 Yes 3 (7.0%) 0 (0.0%) 3 (3.4%)
Coronary artery disease
 Yes 5 (11.6%) 2 (4.4%) 7 (8.0%)
Hypertension
 Yes 21 (48.8%) 25 (55.6%) 46 (52.3%)
Ischemic stroke
 Yes 0 (0.0%) 2 (4.4%) 2 (2.3%)
Current smoker
 No 38 (88.4%) 40 (88.9%) 78 (88.6%)
 Unknown 3 (7.0%) 3 (6.7%) 6 (6.8%)
 Yes 2 (4.7%) 2 (4.4%) 4 (4.5%)
Ever smoked?
 No 20 (46.5%) 21 (46.7%) 41 (46.6%)
 Unknown 3 (7.0%) 4 (8.9%) 7 (8.0%)
 Yes 18 (41.9%) 18 (40.0%) 36 (40.9%)
Time from hospitalization to randomization (days)
 Mean (SD) 3.814 (4.176) 5.114 (5.772) 4.471 (5.060)
Oxygen demand on admission to the hospital?
 No 9 (20.9%) 9 (20.0%) 18 (20.5%)
 Yes 34 (79.1%) 36 (80.0%) 70 (79.5%)
Ventilation
 No 43 (100.0%) 42 (93.3%) 85 (96.6%)
 Yes 0 (0.0%) 3 (6.7%) 3 (3.4%)
Oxygen supply?
 No 5 (11.6%) 6 (13.3%) 11 (12.5%)
 Yes 38 (88.4%) 36 (80.0%) 74 (84.1%)
Oxygen application
 Mask with reservoir 0 (0.0%) 2 (4.4%) 2 (2.3%)
 Mask without reservoir 2 (4.7%) 2 (4.4%) 4 (4.5%)
 Nasal cannula 36 (83.7%) 32 (71.1%) 68 (77.3%)
Creatinine (mg/dL)
 Mean (SD) 0.914 (0.290) 0.889 (0.237) 0.901 (0.263)